Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Vasculitides in older people 

Vasculitides in older people
Chapter:
Vasculitides in older people
Author(s):

Alexis Régent

and Loïc Guillevin

DOI:
10.1093/med/9780198701590.003.0074
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 November 2020

Vasculitides are a heterogeneous group of diseases, defined by vessel inflammation with fibrinoid necrosis of the arterial wall, giant-cell infiltration, and/or granuloma. Patients with giant cell arteritis (GCA) often have headaches, polymyalgia rheumatica, and vision symptoms in a context of moderately impaired health. Microscopic polyangiitis symptoms are very diverse, including alveolar haemorrhage, rapidly progressive glomerulonephritis, skin ulcers, mononeuritis multiplex, muscle, and joint pain. Other vasculitides, such as granulomatosis with polyangiitis (Wegener’s) (GPA) or cryoglobulinemic vasculitis occur less frequently in older patients. Diagnoses are based on clinical manifestations, laboratory results, imaging findings, and the established classification of vasculitides according to vessel size and histological findings. The treatment regimen, based on glucocorticoids and immunosuppressants, is chosen according to diagnosis and predictable outcome, and adapted to the patient’s age and concomitant comorbidities.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.